520 related articles for article (PubMed ID: 32118585)
1. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.
Liu X; Hoft DF; Peng G
J Clin Invest; 2020 Mar; 130(3):1073-1083. PubMed ID: 32118585
[TBL] [Abstract][Full Text] [Related]
2. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
Zhao Y; Shao Q; Peng G
Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
[TBL] [Abstract][Full Text] [Related]
3. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence.
Ye J; Ma C; Hsueh EC; Dou J; Mo W; Liu S; Han B; Huang Y; Zhang Y; Varvares MA; Hoft DF; Peng G
EMBO Mol Med; 2014 Oct; 6(10):1294-311. PubMed ID: 25231413
[TBL] [Abstract][Full Text] [Related]
4. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
5. Senescent T cells: a potential biomarker and target for cancer therapy.
Zhang J; He T; Xue L; Guo H
EBioMedicine; 2021 Jun; 68():103409. PubMed ID: 34049248
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
[TBL] [Abstract][Full Text] [Related]
7. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.
Crespo J; Sun H; Welling TH; Tian Z; Zou W
Curr Opin Immunol; 2013 Apr; 25(2):214-21. PubMed ID: 23298609
[TBL] [Abstract][Full Text] [Related]
8. Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms.
Davoodzadeh Gholami M; Kardar GA; Saeedi Y; Heydari S; Garssen J; Falak R
Cell Immunol; 2017 Dec; 322():1-14. PubMed ID: 29079339
[TBL] [Abstract][Full Text] [Related]
9. Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Oesterreich S; Aird KM
Cancer Immunol Res; 2023 Apr; 11(4):401-404. PubMed ID: 36826438
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy.
Cao Y; Wang X; Jin T; Tian Y; Dai C; Widarma C; Song R; Xu F
Signal Transduct Target Ther; 2020 Oct; 5(1):250. PubMed ID: 33122640
[TBL] [Abstract][Full Text] [Related]
11. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.
Liu X; Hartman CL; Li L; Albert CJ; Si F; Gao A; Huang L; Zhao Y; Lin W; Hsueh EC; Shen L; Shao Q; Hoft DF; Ford DA; Peng G
Sci Transl Med; 2021 Mar; 13(587):. PubMed ID: 33790024
[TBL] [Abstract][Full Text] [Related]
13. Oncology meets immunology: the cancer-immunity cycle.
Chen DS; Mellman I
Immunity; 2013 Jul; 39(1):1-10. PubMed ID: 23890059
[TBL] [Abstract][Full Text] [Related]
14. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
15. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
16. Oncogene-induced senescence: From biology to therapy.
Zhu H; Blake S; Kusuma FK; Pearson RB; Kang J; Chan KT
Mech Ageing Dev; 2020 Apr; 187():111229. PubMed ID: 32171687
[TBL] [Abstract][Full Text] [Related]
17. The Evolving Role of CD8
Huff WX; Kwon JH; Henriquez M; Fetcko K; Dey M
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181772
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory signaling and cellular senescence.
Ren JL; Pan JS; Lu YP; Sun P; Han J
Cell Signal; 2009 Mar; 21(3):378-83. PubMed ID: 18992324
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment.
Ma F; Vayalil J; Lee G; Wang Y; Peng G
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
